News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Brudnick Richard
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/04/2023 |
4
| Brudnick Richard (Chief Business Officer) has filed a Form 4 on Prime Medicine, Inc.
Txns:
| Granted 135,747 options to buy
@ $12.3, valued at
$1.7M
|
|
01/13/2023 |
4
| Brudnick Richard (Director) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 5,625 shares
@ $0 |
|
10/14/2022 |
4
| Brudnick Richard (Director) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 2,625 shares
@ $0 |
|
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| Brudnick Richard (Director) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 1,640 shares
@ $0 Granted 3,022 options to buy
@ $3.4, valued at
$10.3k
|
|
02/18/2022 |
4
| Brudnick Richard (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 10,850 options to buy
@ $5.21, valued at
$56.5k
Granted 16,275 restricted stock units
@ $0 |
|
01/21/2022 |
4
| Brudnick Richard (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 41,000 options to buy
@ $7.21, valued at
$295.6k
Granted 8,400 restricted stock units
@ $0 |
|
03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2021 |
4
| Brudnick Richard (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 31,000 options to buy
@ $26.6, valued at
$824.6k
|
|
03/08/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns:
| Disposed/sold 22,952 shares
@ $0 Disposed/sold 7,489 restricted stock units
@ $0 Disposed/sold 31,818 restricted stock units
@ $0 Disposed/sold 14,899 options to buy
@ $44.51, valued at
$663.2k
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
|
|
02/26/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns:
| Paid exercise price by delivering 1,419 shares
@ $104.3, valued at
$148k
Paid exercise price by delivering 924 shares
@ $104.74, valued at
$96.8k
|
|
02/15/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns:
| Paid exercise price by delivering 1,137 shares
@ $103.52, valued at
$117.7k
Exercised 3,744 restricted stock units
@ $0 |
|
02/02/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns:
| Granted 31,818 restricted stock units
@ $0 |
|
03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|